Carmen Aceijas

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Global overview of injecting drug use and HIV infection among injecting drug users
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, Department of Primary Care and Social Medicine, Imperial College, London, UK
    AIDS 18:2295-303. 2004
  2. ncbi Global estimates of prevalence of HCV infection among injecting drug users
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, University of London, London, UK
    Int J Drug Policy 18:352-8. 2007
  3. ncbi Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5")
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Addiction 101:1246-53. 2006
  4. ncbi Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, London School of Hygiene and Tropical Medicine LSHTM, Department of Public Health and Policy, London, UK
    Addiction 102:1244-50. 2007
  5. ncbi HIV in prison in low-income and middle-income countries
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Lancet Infect Dis 7:32-41. 2007

Detail Information

Publications5

  1. ncbi Global overview of injecting drug use and HIV infection among injecting drug users
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, Department of Primary Care and Social Medicine, Imperial College, London, UK
    AIDS 18:2295-303. 2004
    ..To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries...
  2. ncbi Global estimates of prevalence of HCV infection among injecting drug users
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, University of London, London, UK
    Int J Drug Policy 18:352-8. 2007
    ..In this paper, we review evidence of HCV prevalence among injecting drug users (IDUs) worldwide...
  3. ncbi Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5")
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Addiction 101:1246-53. 2006
    ..To describe and estimate the availability of antiretroviral treatment (ART) to injecting drug users (IDUs) in developing and transitional countries...
  4. ncbi Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia
    Carmen Aceijas
    Centre for Research on Drugs and Health Behaviour CRDHB, London School of Hygiene and Tropical Medicine LSHTM, Department of Public Health and Policy, London, UK
    Addiction 102:1244-50. 2007
    ..To estimate access, activity and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia...
  5. ncbi HIV in prison in low-income and middle-income countries
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Lancet Infect Dis 7:32-41. 2007
    ..Systematic collection of data to inform HIV prevention strategies in prison is urgently needed. The introduction and evaluation of HIV prevention strategies in prisons are warranted...